CMAJ • November 20, 2007; 177 (11). doi:10.1503/cmaj.061730.
© 2007 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Résumé
Right arrow Online Appendix
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kent, W. D.T.
Right arrow Articles by Groome, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kent, W. D.T., MSc MD
Right arrow Articles by Groome, P. A., PhD
Related Collections
Right arrow Other endocrinology
Right arrow Other cancers
Right arrowRelated Article

Research

Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease

William D.T. Kent, MSc MD, Stephen F. Hall, MSc MD, Phillip A. Isotalo, MD, Robyn L. Houlden, MD, Ralph L. George, MD and Patti A. Groome, PhD

From the Departments of Surgery [General Surgery] (Kent), Otolaryngology (Hall), Pathology and Molecular Medicine (Isotalo), Medicine [Endocrinology] (Houlden) and Surgery [Surgical Oncology] (George), Queen's University; and the Division of Cancer Care and Epidemiology (Groome), Cancer Research Institute at Queen's University, Kingston, Ont.

Correspondence to: Dr. Stephen F. Hall, Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, 10 Stuart St., Kingston ON K7L 3N6, fax 613 533-6794; sfh{at}post.queensu.ca

Background: Recent reports from North America and Europe have documented an annual increase in the incidence of differentiated thyroid carcinoma. We sought to investigate the relation between rates of detection, tumour size, age and sex.

Methods: Using the Ontario Cancer Registry, we identified 7422 cases of differentiated thyroid carcinoma diagnosed from Jan. 1, 1990, to Dec. 31, 2001. We obtained pathology reports for a random 10% of the 7422 patients for each year of the study period. The sample represented all Cancer Care Ontario regions. We compared the size of the patients' tumours by year, sex and age.

Results: As expected, the incidence of differentiated thyroid carcinoma increased over the 12-year period. A significantly higher number of small (≤ 2 cm), nonpalpable tumours were resected in 2001 than in 1990 (p = 0.001). The incidence of tumours 2–4 cm in diameter remained stable. When we examined differences in tumour detection rates by age and sex, we observed a disproportionate increase in the number of small tumours detected among women and among patients older than 45 years.

Interpretation: Our findings suggest that more frequent use of medical imaging has led to an increased detection rate of small, subclinical tumours, which in turn accounts for the higher incidence of differentiated thyroid carcinoma. This suggests that we need to re-evaluate our understanding of the trends in thyroid cancer incidence.


Related Article

Explaining the increasing incidence of differentiated thyroid cancer
Jacques How, MB ChB and Roger Tabah, MD
Can. Med. Assoc. J. 2007 177: 1383-1384. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
P. Miccoli, A. Pinchera, G. Materazzi, A. Biagini, P. Berti, P. Faviana, E. Molinaro, D. Viola, and R. Elisei
Surgical Treatment of Low- and Intermediate-Risk Papillary Thyroid Cancer with Minimally Invasive Video-Assisted Thyroidectomy
J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1618 - 1622.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. Enewold, K. Zhu, E. Ron, A. J. Marrogi, A. Stojadinovic, G. E. Peoples, and S. S. Devesa
Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005
Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 784 - 791.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
G. Sassolas, Z. Hafdi-Nejjari, L. Remontet, N. Bossard, A. Belot, N. Berger-Dutrieux, M. Decaussin-Petrucci, C. Bournaud, J. L. Peix, J. Orgiazzi, et al.
Thyroid cancer: is the incidence rise abating?
Eur. J. Endocrinol., January 1, 2009; 160(1): 71 - 79.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
L. D. Marrett PhD, P. De MHSc PhD, P. Airia MD MSc, D. Dryer MD, and for the steering committee of Canadian Cancer Stat
Cancer in Canada in 2008
Can. Med. Assoc. J., November 18, 2008; 179(11): 1163 - 1170.
[Full Text] [PDF]

Home page
 CMAJHome page
J. How MB ChB and R. Tabah MD
Explaining the increasing incidence of differentiated thyroid cancer
Can. Med. Assoc. J., November 20, 2007; 177(11): 1383 - 1384.
[Full Text] [PDF]